Assessing Dental Care Utilization Status and Caregiver Satisfaction with Dental Treatment for Pediatric Patients with Rare Diseases

Article information

J Korean Acad Pediatr Dent. 2025;52(2):221-238
Publication date (electronic) : 2025 May 20
doi : https://doi.org/10.5933/JKAPD.2025.52.2.221
1Department of Pediatric Dentistry, College of Dentistry, Yonsei University, Seoul, Republic of Korea
2Department of Pediatric Dentistry and Institute of Oral Bioscience, School of Dentistry, Jeonbuk National University, Jeonju, Republic of Korea
3Department of Pediatric Dentistry, Dental and Life Science Institute & Dental Research Institute, School of Dentistry, Pusan National University, Yangsan, Republic of Korea
4Department of Pediatric Dentistry, School of Dentistry, Kyungpook National University, Daegu, Republic of Korea
Corresponding author: Chung-Min Kang Department of Pediatric Dentistry, College of Dentistry, Yonsei University, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea Tel: +82-2-2228-3174 / Fax: +82-2-365-7420 / E-mail: KANGCM@yuhs.ac
Received 2025 February 5; Revised 2025 March 5; Accepted 2025 March 10.

Trans Abstract

This study aimed to investigate the dental utilization status, satisfaction with dental treatment, and the need for improvement among pediatric patients with rare diseases in Korea. A survey was conducted from June 2023 to May 2024 among caregivers of patients with rare diseases who visited the pediatric dentistry departments of eight dental institutions. The questionnaire for this study was divided into two sections: 126 caregivers participated in the dental utilization survey, while 91 caregivers completed the survey on satisfaction with dental treatment. Many caregivers believed that the patient’s poor oral health could impact overall health and reported positive functional and psychological changes following dental treatment. However, dental care for these patients presents challenges due to insufficient oral care information, specialized dentists, specialized dental facilities, and insurance coverage. Caregivers identified the need for an increase in specialized dental facilities as the highest priority (42.9%), with many emphasizing the necessity for expanded insurance coverage (38.9%). Notably, caregivers of patients who had undergone dental caries treatment advocated for broader insurance coverage (p = 0.0141), particularly for prosthetic (p = 0.0330) and restorative treatments (p = 0.0129). Furthermore, caregivers of patients with congenital disorders reported a significant economic burden associated with orthodontic treatment (p = 0.0405). Additionally, caregivers emphasized the need for an increase in specialized dentists (33.3%) and improved collaboration with pediatricians (25.4%). This study underscores the critical necessity for tailored policies and comprehensive support systems that reflect the current needs of the dental care system for pediatric patients with rare diseases.

Introduction

In Korea, a rare disease is defined as a medical condition characterized by a prevalence of fewer than 20,000 individuals or an indeterminate prevalence due to challenges associated with diagnosis, as established by the protocols and criteria outlined by the Ministry of Health and Welfare [1].

According to statistical data provided by the Korea Disease Control and Prevention Agency, as of January 1, 2022, 1,123 rare diseases have been formally documented, with 54,952 cases of rare diseases reported in Korea in 2022. Among high-frequency diseases (defined as those affecting more than 200 individuals), the classification of patients by age revealed that 1.0% were under 1 year of age, 1.8% were between 1 and 9 years, and 5.4% were between 10 and 19 years of age. By 2022, it was estimated that approximately 8.2% of patients with rare diseases were pediatric. Representative pediatric rare diseases include Crohn’s disease, Moyamoya disease, systemic lupus erythematosus, tetralogy of Fallot, epilepsy, juvenile rheumatoid arthritis, spina bifida, microtia, and neurofibromatosis [2]. As of February 2025, 1,314 rare diseases have been officially recognized by the Korea Disease Control and Prevention Agency [3].

Approximately 15% of patients with rare diseases experience orofacial complications [4]. Abnormal growth of the craniofacial region often leads to orofacial anomalies, such as dysgnathia and clefts [5], with a high incidence of malocclusion, including anterior open bite and high palate [6-8]. In addition, genetic defects may lead to dental developmental abnormalities such as tooth agenesis [9-11], microdontia [12,13], and enamel hypoplasia [6], and may also be associated with xerostomia [6]. In patients with rare diseases, not only complications but also conditions that hinder oral hygiene can lead to dental issues [14,15]. Patients with intellectual disabilities, executive function disorders, or learning disabilities often struggle to maintain oral hygiene [16,17], thereby increasing the risk of dental caries and gingival-periodontal disease [18-21]. Furthermore, maladaptive oral habits such as bruxism, mouth breathing, and tongue thrusting have been reported [6].

Poor oral health in patients with rare diseases can hinder proper nutrition, induce pain, and disrupt sleep, speech, and daily activities, ultimately decreasing their quality of life and significantly impacting their overall health [19,22-24]. Therefore, there is a need to focus on dental care to improve the overall health and quality of life of patients with rare diseases. Given that many rare diseases manifest during childhood [25], preventive approaches and early interventions in dental care are essential for pediatric patients with rare diseases [26], highlighting the important role of pediatric dentists.

Despite this importance, dental care for patients with rare diseases remains challenging due to several factors: (i) Managing oral hygiene is difficult due to the heavy daily routines of patients with rare diseases and a lack of awareness and information regarding oral care among caregivers [14,26]. (ii) Presently, 16 regional oral health centers for individuals with disabilities operate in Korea, and some university dental hospitals have specialized clinics for dental care of individuals with disabilities [27]. However, there are no officially designated dental care facilities specifically for patients with rare diseases. Although 17 regional specialized institutions for the management of rare diseases operate in Korea, none of these institutions have a dental department within their rare disease centers [28]. Consequently, patients with rare diseases who also have disabilities receive dental care at regional oral health centers for individuals with disabilities or specialized clinics in university dental hospitals, while those without disabilities receive dental care at general dental facilities. (iii) The unique characteristics of rare diseases make specialized dental interventions challenging in primary care institutions, which often lack the requisite expertise in behavioral management and understanding of systemic conditions [26,29,30]. (iv) Limited cognitive and motor development in patients with rare diseases poses challenges in accessing advanced dental institutions [31]. (v) In Korea, policies are in place to provide financial support for certain reimbursable medical expenses for patients with rare diseases registered as beneficiaries under the special case program [32]. However, most non-reimbursable dental treatments are excluded from this coverage. Furthermore, some dental procedures are covered for patients with rare diseases who are also diagnosed with brain lesions, intellectual disabilities, mental disorders, or autism spectrum disorders [33,34]. However, these covered procedures are confined to specific items, such as fluoride application and general anesthesia during dental treatment, and are only applicable to those with an associated disability diagnosis. Consequently, the financial support for dental care specifically tailored to patients with rare diseases remains inadequate.

Therefore, developing appropriate policies and management guidelines to facilitate dental care in patients with rare diseases is imperative. To achieve this, an evaluation of the current dental care status for these patients, as well as their satisfaction and needs concerning dental care, is essential. One study examined the dental treatment patterns of pediatric patients with rare diseases at a single institution in Korea and highlighted the significance of personalized dental care for these individuals [35]. Nevertheless, to date, no nationwide multicenter cohort study has been conducted on the dental care utilization of pediatric patients with rare diseases in Korea, nor has any research focused on caregivers’ perceptions, satisfaction, and needs regarding the dental care of these children.

Therefore, the purpose of this study was to investigate dental care utilization and satisfaction with dental treatment among patients with rare diseases who visited a dental hospital and to provide data for future policy recommendations.

Materials and Methods

1. Study population

The study population comprised caregivers of patients with rare diseases who visited the Department of Pediatric Dentistry in dental hospitals across eight institutions between July 2023 and May 2024. The study specifically focused on caregivers of patients with conditions classified as rare diseases, as registered by the Korea Disease Control and Prevention Agency, totaling 1,248 conditions (as of 2024). A total of 126 caregivers of patients with rare diseases responded to a survey on dental care utilization, and 91 caregivers participated in a survey regarding their satisfaction with dental treatment. This study was approved by the Institutional Review Board of the Yonsei University Dental Hospital (Approval No. 2-2023-0025). Informed consent was obtained from all participants.

2. Methods

The general characteristics of the pediatric patients with rare diseases and information regarding their conditions were confirmed through electronic medical records and caregiver interviews. Caregivers of patients with rare diseases who visited the Department of Pediatric Dentistry at the eight dental hospitals were informed about the survey by staff members and completed the questionnaire after providing their consent. The questionnaire was divided into two distinct sections, comprising 33 questions. The first section assessed caregivers’ perceptions of the dental care utilization status of pediatric patients with rare diseases, their perceptions of the oral and overall health of these patients, reasons for dental visits, factors influencing the choice of dental hospital, modes of transportation, barriers to accessing dental care, and frequency of dental check-ups (Fig. 1). The second section evaluated functional and psychological satisfaction following dental treatment by inquiring about changes in pain, discomfort, eating, chewing, overall health, confidence, and happiness. Additionally, the need for enhancements in the dental care system for patients with rare diseases, including cost considerations, was investigated (Fig. 2). An online database was established using an electronic case report form, and patient information and survey results were collected from each institution. Within the survey results, each option of the single-choice questions was assigned a score based on a 5-point scale, facilitating the calculation of average scores to quantify responses for each question. Higher scores indicated more positive responses.

Fig 1.

Survey questionnaire on dental utilization among pediatric patients with rare diseases.

Fig 2.

Survey questionnaire on satisfaction with dental treatment for pediatric patients with rare diseases.

3. Statistical analysis

Statistical analyses were performed using IBM SPSS Statistics version 26.0 (IBM Corp., Armonk, NY, USA). The Chi-square tests and Fisher’s exact tests were conducted to analyze the dental care utilization status in pediatric patients with rare diseases based on whether primary physicians recommended dental check-ups or explained the importance of oral care. Additionally, Chisquare and Fisher’s exact tests were utilized to assess the requirements for improving the dental care system for pediatric patients with rare diseases based on the recent experiences of dental caries treatment within the past 6 months and the classification of rare diseases. A minimum significance level of 5% (α = 0.05) was adopted.

Results

1. Characteristics of the study participants

Among the patients with rare diseases included in the study, 63 (50%) were male, and 63 (50%) were female. The most common age at the first dental visit was 0 – 5 years, accounting for 74 patients (58.7%), followed by ages 6 – 10 years with 39 patients (31%), and 11 – 15 years with 13 patients (10.3%). A majority of patients resided in metropolitan areas, with 24 (19.1%) in Seoul and 33 (26.2%) in Gyeonggi Province (Table 1). According to the Korea Disease Control and Prevention Agency’s classification of rare diseases, 33 patients (26.2%) had neurological diseases, such as Lennox-Gastaut syndrome; 68 patients (54.0%) had congenital disorders, such as Down syndrome; and 25 patients (19.8%) had other diseases, such as Moyamoya disease (Fig. 3). Regarding the timing of rare disease diagnosis, the largest proportion of 50 patients (41.7%) was diagnosed within the first year of life. Additionally, only one patient (0.9%) had a family history of a rare disease, and 75 patients (61.5%) were taking medication for their condition. Among all patients with rare diseases, the majority (111 patients, 91%) were classified as ASA (American Society of Anesthesiologists) class II (Table 1).

Demographic characteristics of the study

Fig 3.

Representative diseases according to rare disease classification.

2. Survey on dental care utilization among pediatric patients with rare disease

Caregivers’ perceptions of the dental care utilization status for patients with rare diseases

The overall perception was that information on oral care, specialized dentists, specialized dental care facilities, and insurance coverage was insufficient, with average scores of 2.5, 2.2, 2.1, and 2.0 out of 5, respectively (Fig. 4A).

Fig 4.

Caregivers’ perceptions of and satisfaction with dental care for pediatric patients with rare diseases. (A) Caregivers’ perceptions of the dental care utilization status for patients with rare diseases, (B) Caregivers’ perceptions of the oral and general health status of patients with rare diseases, (C) Caregivers’ perceptions of functional and psychological changes after dental treatment, (D) The average score for each response is displayed on the right side of the horizontal bar. Higher scores indicate more positive responses.

Caregivers’ perceptions of the oral and general health status of patients with rare diseases

Caregivers rated the current oral health status of children with rare diseases at 2.3 out of 5. The response to the question regarding the relationship between oral health and overall health was 3.9 out of 5, reflecting a general awareness of this association. The perception of the connection between the current oral health of children and overall health was rated at 3.3 out of 5. These results suggest that caregivers generally perceived their child’s current oral health as poor and believed that this negatively impacted their child’s overall health (Fig. 4B).

Current status of dental care utilization for pediatric patients with rare diseases

The primary reasons for dental visits among pediatric patients with rare diseases included regular check-ups (61.1%), recommendations from primary physicians (32.5%), difficulty in eating (12.7%), pain (11.9%), and aesthetic concerns (7.1%). Additionally, 8.7% of patients visited the hospital for other reasons, such as trauma or malocclusion. Among the caregivers, 58 (46.0%) reported having been advised by their primary physician to seek dental check-ups and treatment, and 56 (44.4%) were informed of the importance of oral care. This indicates that more than half of the caregivers did not receive oral care recommendations from their primary physicians. Patients with rare diseases who reported being encouraged by their primary physician to undergo dental checkups were more likely to visit the dentist based on these recommendations than those who did not receive such encouragement (p= 0.0001). Furthermore, individuals who were informed by their primary physician about the importance of oral care were more likely to visit the dentist for regular check-ups than those who had not received such information (p= 0.0127).

Factors influencing the choice of dental hospital included the expertise of the dental staff (54.8%), collaborative care with pediatrics they were already attending to (52.4%), dental equipment and facilities (39.7%), friendly dental staff (27.8%), recommendations and reputation (14.3%), and proximity as well as the availability of quick appointments and treatment (11.9%). Additionally, 6.4% chose their hospital for other reasons, such as challenges in receiving treatment at private dental clinics and the provision of disability-friendly treatment facilities.

The most common mode of transportation for dental visits was personal vehicles (84.1%), followed by buses and subways (9.5%), specialized transportation for individuals with disabilities (6.4%), taxis (4.8%), and trains and airplanes (2.4%).

The predominant barrier cited for dental visits among pediatric patients with rare diseases was the child’s cooperation (43.7%), followed by limited accessibility to specialized dental hospitals and refusal of treatment at private dental clinics (both at 30.2%). Other barriers included dental expenses (19.1%), transportation difficulties (5.6%), and miscellaneous concerns (7.1%) such as lack of information and clinical experience regarding rare diseases.

The most common dental check-up interval reported was every 3 months (45.2%), followed by every 6 months (37.4%), every 1 – 2 months, and as needed when discomfort arose (7%).

Among the patients included in the study, 47.9% reported having received treatment for dental caries within the past 6 months (Table 2).

Dental care utilization status in pediatric patients with rare diseases based on the primary physician’s recommendation for oral care

3. Survey on satisfaction with dental treatment for pediatric patients with rare disease

Caregivers’ perceptions of functional and psychological changes after dental treatment

Regarding changes in caregivers’ happiness, the average score was 4.2 out of 5, indicating a slight improvement. Regarding the perceived impact of dental treatment on overall health, the average response was 4.0 out of 5, indicating that many believed dental treatment resulted in a positive impact on children’s overall health. Responses regarding the presence of tooth pain postdental treatment among pediatric patients with rare diseases yielded an average of 3.9 out of 5, suggesting that most patients reported very mild pain or none at all. The average score for changes in the child’s overall condition was 3.5 out of 5, with many reporting that the condition was similar or slightly improved. Changes in the child’s happiness and confidence after dental treatment averaged 3.4 and 2.7 out of 5, respectively, with most caregivers reporting that these attributes remained unchanged or had slightly improved. Concerning changes in oral discomfort, the average response was 3.4 out of 5, indicating a slight improvement. The average scores for changes in chewing ability, eating habits, and picky eating were 3.1 and 2.9 out of 5, respectively, with many reporting no significant changes or slight improvements. Concerning appetite, the average response was 2.8 out of 5, indicating that most participants experienced no significant changes. However, despite the broad consensus regarding positive changes following treatment, the average score for the children’s current oral health status was 2.6 out of 5, suggesting that many caregivers still perceived it as poor (Fig. 4C).

Caregivers’ requests for improved dental care for pediatric patients with rare diseases

Among the items that posed a significant economic burden related to dental treatment of pediatric patients with rare diseases, general anesthesia and hospitalization were the most common (31.8%). This was followed by orthodontic and prosthetic treatments each at 30.2%, restorative treatment at 15.1%, endodontic treatment at 10.3%, and fluoride application at 4.8%. Regarding the items for which insurance coverage is deemed necessary during dental treatment for pediatric patients with rare diseases, prosthetic treatment was the most common at 46.8%, followed by orthodontic treatment at 46%, general anesthesia and hospitalization at 36.5%, restorative treatment at 31%, endodontic treatment at 21.4%, and fluoride application at 18.3%. The item that required the most improvement in the dental care system for pediatric patients with rare diseases was the increase in specialized dental facilities (42.9%). This was followed by an expansion of insurance coverage at 38.9%, an increase in specialized dentists at 33.3%, collaborative care with pediatrics at 25.4%, and the provision of oral care information at 11.1%.

Patients who reported receiving dental caries treatment within the past 6 months were more likely to highlight the need for insurance coverage for prosthetic (p= 0.0330) and restorative treatments (p= 0.0129) than those who did not. Furthermore, these patients underscored the need to expand insurance coverage for dental treatment within the dental care system for children with rare diseases (p= 0.0141).

Additionally, based on the classification of rare diseases, patients with congenital disorders reported a greater economic burden of orthodontic treatment than those with other conditions (p= 0.0405), emphasizing the need to expand the availability of specialized dentists (p= 0.0015, Table 3).

Caregivers’ requests for improved dental care for children with rare diseases based on dental caries treatment experiences and rare disease classification

Discussion

This study was performed to assess the current status of dental care utilization among pediatric patients with rare diseases through a survey of their caregivers. Additionally, it investigated caregivers’ perceptions regarding the dental care and oral health of their children alongside their satisfaction with dental treatment. The goal was to provide reference data for developing improved support systems and facilities related to the dental treatment of pediatric patients with rare diseases. The findings present a nationwide overview of dental care utilization among children with rare diseases in Korea and emphasize the requests of caregivers for enhancements in the dental care system. A summary of the main findings is illustrated in Fig. 5.

Fig 5.

Graphical summary of the main findings of this study.

This figure illustrates the factors contributing to the challenges in providing dental care for children with rare diseases (red arrows on the left) and the requirements for improving dental care for these patients (green arrows on the right).

In this study, rare diseases were classified into three categories: (i) congenital disorders, which are likely to be accompanied by structural anomalies in the oral and maxillofacial region [7,9,11-13,20]; (ii) neurological diseases, which may involve cognitive and motor limitations, complicating oral hygiene management [20]; and (iii) other diseases. Congenital disorders accounted for more than half of the cases (54.0%), including Down syndrome‒a chromosomal disorder that causes intellectual disability due to the triplication of chromosome 21 [36]; atrioventricular septal defect‒a congenital heart defect [37]; craniosynostosis‒a condition characterized by the premature and incomplete fusion of one or more cranial sutures, leading to an abnormal shape of the skull [38]; Cri-du-chat syndrome‒a genetic disorder resulting from a deletion on the short arm of chromosome 5, characterized by maxillofacial underdevelopment, developmental delay, and intellectual disability [39]; and Williams syndrome‒caused by a microdeletion of chromosome 7, resulting in developmental and physical abnormalities, including cardiovascular abnormalities, intellectual disability, and growth deficiency [40]. Neurological diseases represented 26.2% of the cases, including Lennox-Gastaut syndrome‒the most severe epileptic encephalopathy characterized by various seizures [41]; West syndrome‒presenting with infantile spasms and developmental delay [42]; status epilepticus‒wherein continuous seizures persist for prolonged periods or recurrent seizures occur without full recovery of consciousness [43]; and Duchenne muscular dystrophy‒a genetic disorder that causes muscle weakness and leads to delays in motor and language development [44]. Other diseases included Moyamoya disease‒a rare condition characterized by the progressive stenosis of brain arteries that can lead to stroke [45]; Mowat-Wilson syndrome‒ a genetic disorder associated with characteristic facial features, intellectual and developmental disabilities, and congenital malformations [46]; mucopolysaccharidosis‒ a group of rare lysosomal storage diseases caused by genetic defects, characterized by characteristic facial features, a large tongue, and intellectual impairment [47]; nonobstructive hypertrophic cardiomyopathy‒a genetic heart muscle disease [48]; and Rett syndrome‒a severe neurodevelopmental disorder characterized by developmental regression [49].

In this study, most pediatric patients with rare diseases underwent dental check-ups every 3 – 6 months, and 47.9% had received dental caries treatment within the past 6 months. Regular check-ups accounted for the predominant reason for dental visits (61.1%), followed by recommendations from primary physicians (32.5%). In contrast, visits prompted by symptoms such as difficulty eating or experiencing pain were less frequent (12.7% and 11.9%, respectively). The high proportion of preventive care visits suggests that many caregivers acknowledge the importance of dental care for children with rare diseases and actively engage in dental visits for preventive purposes. The relatively low proportion of visits provoked by symptoms may be attributed to caregivers recognizing the need for oral care or being encouraged by primary physicians to attend dental clinics for preventive purposes. Furthermore, limited communication capabilities among some children with rare diseases may hinder their ability to express symptoms, contributing to fewer prompted visits [20]. In fact, in this study, caregivers primarily acknowledged that children with rare diseases currently have poor oral health, which could adversely affect their overall health. However, caregivers also reported a lack of resources concerning various aspects of dental care, encompassing information on oral health, specialized dentists, specialized dental care facilities, and insurance coverage. These findings suggest that, despite recognizing the necessity of dental management for children with rare diseases, caregivers encounter challenges due to insufficient information, inadequate facilities, and limited support structures available to fulfill their needs. Moreover, more than half of the caregivers reported that their primary physician had not advised them to schedule dental check-ups or informed them about the importance of oral care for their rare disease. In contrast, caregivers receiving guidance or clarification from primary physicians were more inclined to pursue dental visits for preventive purposes. Consequently, it is essential to enhance access to relevant information concerning dental care for children with rare diseases and collaborate with pediatricians to promote preventive dental visits.

The primary reasons influencing the selection of a dental hospital included the expertise of the dental staff and collaborative care with pediatricians (54.8% and 52.4%, respectively), followed by dental equipment and facilities (39.7%). In contrast, geographical proximity was deemed less significant (11.9%). This suggests that caregivers prioritize factors such as the specialized dentists, collaborative relations with medical departments, and the accessibility of dental facilities and equipment suitable for addressing the unique needs posed by their child’s rare disease, rather than focusing on the hospital’s location. This highlights the necessity of training specialized dentists, fostering collaborative care with pediatricians, and establishing dental facilities equipped to manage and treat the specific challenges faced by patients with rare diseases. Therefore, it is necessary to establish specialized dental facilities, such as dental departments within rare disease centers or dental facilities that collaborate efficiently with related medical departments. Additionally, developing dental facilities with specialized infrastructure and equipment can improve accessibility for patients with physical impairments. Furthermore, training specialized dentists who are qualified as dental specialists and possess knowledge and clinical experi-ence in rare diseases would enable safer and more tailored dental care for these patients.

The most common barrier to accessing dental care cited was the lack of cooperation from the child (43.7%), followed by limited accessibility to specialized dental hospitals and refusal of treatment at primary care institutions (both at 30.2%). These results underscore the difficulties associated with providing dental care for children with rare diseases, attributed to cognitive and motor limitations, barriers in accessing specialized dental care at primary care institutions, and the shortage of specialized dental hospitals. This suggests the need to expand dental care facilities tailored to the needs of children with rare diseases.

Furthermore, among the factors perceived as challenges to dental visits, the financial burden stood at 19.1%, indicating that caregivers encounter substantial financial challenges. In terms of the economic burden of dental treatment for children with rare diseases, the most expensive procedures were general anesthesia and hospitalization (31.8%), followed by orthodontic and prosthetic treatments (30.2% each), restorative treatment (15.1%), endodontic treatment (10.3%), and fluoride application (4.8%). Patients with rare diseases are often treated under general anesthesia and require hospitalization due to anticipated difficulties with cooperation during dental procedures, attributable to cognitive and motor development impairments or the need for more complex treatments such as prosthetic treatment, and surgical procedures due to structural anomalies in the oral and maxillofacial region [20,35]. Consequently, the financial implications arising from general anesthesia and hospitalization can be considerable. Moreover, orthodontic and prosthetic treatments tend to be classified as high-cost procedures, particularly as they often remain outside the ambit of insurance coverage, thereby amplifying the financial impact on caregivers. In contrast, restorative and endodontic treatments are more likely to receive insurance coverage, with fluoride applications also being covered for patients who have brain lesions, intellectual disabilities, mental disorders, or autism, indicating that the financial burden associated with these treatments is comparatively lower. Regarding treatments that are considered to be covered by insurance, the three most frequently mentioned were prosthetic treatment (46.8%), orthodontic treatment (46.0%), and general anesthesia accompanied by hospitalization (36.5%), followed by restorative treatment (31.0%), endodontic treatment (21.4%), and fluoride application (18.3%). The financial burden and recognition concerning the necessity for insurance coverage tended to be greater for restorative treatments than for endodontic treatments, likely reflecting the higher frequency of restorative treatments compared to endodontic treatments [35] and the fact that a significant portion of restorative treatments remains uncovered by insurance. Caregivers whose children underwent dental caries treatment within the past 6 months were more likely to express a need for insurance coverage across all treatment modalities compared to those who did not, predominantly expressing a need for prosthetic and restorative treatments. This observation points to a heightened awareness among caregivers of patients recently undergoing dental caries treatment regarding the financial burden and insurance coverage needs related to prosthetic and restorative treatments. Therefore, the burden of non-reimbursable dental treatments is substantial, emphasizing the necessity for systems that provide insurance coverage or financial support for these treatments.

The findings from the satisfaction survey related to dental treatment indicated that many caregivers regarded dental care as having a positive influence on their children’s overall health. They also reported improvements in children’s pain, oral discomfort, and masticatory function, along with increased happiness for both the caregiver and the child. These findings align with existing literature on the impact of oral health among children with rare diseases on their quality of life and overall health and demonstrate the positive outcomes associated with dental care for patients with rare diseases, underscoring the need for more accessible and accommodating dental care measures for these children.

The most prevalent requests for improvements within the dental care system included increasing specialized dental care facilities (42.9%), expanding insurance coverage (38.9%), increasing specialized dentists (33.3%), facilitating collaborative care with pediatricians (25.4%), and enhancing the availability of oral health information (11.1%). Furthermore, those who had undergone dental caries treatment within the preceding 6 months were more likely to articulate a stronger need for expanded insurance coverage compared to those who had not, indicating that caregivers with recent dental treatment experiences possess a heightened awareness of the necessity for broader insurance provisions. These results highlight the deficiencies in specialized dental care facilities, insurance coverage, and specialized dentists for children with rare diseases, further emphasizing the need for efforts to address these challenges.

According to the classification of rare diseases, the caregivers of patients with congenital disorders reported a higher financial burden for orthodontic treatment than those with other diseases and emphasized the need for more specialized dentists. Patients with congenital disorders often experience oral and maxillofacial complications that frequently require orthodontic treatment [5,20], and the percentage of patients undergoing such treatment is higher than that in other disease groups [35]. However, in Korea, insurance coverage for orthodontic treatment is currently restricted to patients with cleft lip and palate and those with specific congenital anomalies, such as cleidocranial dysostosis, craniofacial dysostosis, Crouzon’s disease, and acrocephalosyndactyly [50]. As a result, the majority of orthodontic treatments remain uncovered, placing a substantial financial burden on caregivers. Furthermore, due to the heightened likelihood of dental complications, caregivers of patients with congenital disorders articulate a compelling need for dental professionals with specialized knowledge regarding rare diseases and their associated complications. Thus, the establishment of tailored support systems that comprehensively address the specific requirements of patients with rare diseases is of paramount importance.

This study has several limitations. First, it did not encompass caregivers’ perceptions of dental care for healthy children without rare diseases, thereby precluding a comparative analysis with a control group. Second, being a survey-based study, the potential for inaccuracies in responses exists due to factors such as careless answering or a lack of comprehensive understanding of the questions posed.

Despite these limitations, this study possesses several strengths. First, rare diseases impact a very small patient population; hence, investigating the perceptions and needs of caregivers for these patients is significant in itself and represents the first study of its kind. Second, as a nationwide multicenter cohort study focusing on the dental care status of pediatric patients with rare diseases, this research offers a representative overview of the situation in Korea.

Conclusion

The oral health of pediatric patients with rare diseases is closely intertwined with their overall health and quality of life, rendering dental care critically important for them. In fact, in this study, many caregivers of children with rare diseases reported experiencing positive changes, both functional and psychological, following dental treatment for their children. However, according to this study, in Korea, despite caregivers acknowledging the necessity of oral health care for children with rare diseases, challenges in providing adequate dental care persist, attributed to a lack of patient cooperation, insufficient oral care information, and a shortage of specialized dentists and facilities, compounded by limited insurance coverage. Caregivers emphasized the urgent need to enhance the dental care system for children with rare diseases by expanding specialized dental facilities, increasing the number of specialized dentists, enhancing insurance coverage, and fostering collaborative care with pediatricians. Furthermore, caregivers of patients with prior experiences of dental caries treatment stressed the necessity to broaden insurance coverage, especially for prosthetic and restorative treatments. Therefore, to improve dental care for children with rare diseases, it is essential to promote preventive dental visits in collaboration with pediatricians. Furthermore, tailored policies and comprehensive support systems are needed that include expanded insurance coverage, an increase in specialized dentists, and the expansion of specialized dental facilities.

Notes

Acknowledgments

This research was supported and funded by SNUH Lee Kun-hee Child Cancer & Rare Disease Project, Republic of Korea (grant number: 23C-033-0100).

Conflicts of Interest

The authors have no potential conflicts of interest to disclose.

Funding information

This research was supported and funded by SNUH Lee Kun-hee Child Cancer & Rare Disease Project, Republic of Korea (grant number: 23C-033-0100).

References

1. Korea Disease Control and Prevention Agency. 2022 Annual Report on the Rare Disease Patients in Korea Korea Disease Control and Prevention Agency. Cheongju: 22024.
2. Korea Disease Control and Prevention Agency. 2022 Annual Report on the Rare Disease Patients in Korea Korea Disease Control and Prevention Agency. Cheongju: p. 68–77. 2024.
3. Korea Disease Control and Prevention Agency. Information of rare disease. Available from URL: https://helpline.kdca.go.kr/cdchelp/ph/rdiz/selectRdizInfList.do?menu=A0100 (Accessed on February 3, 2025).
4. Hanisch M, Hanisch L, Benz K, Kleinheinz J, Jackowski J. Development of a database to record orofacial manifestations in patients with rare diseases: A status report from the ROMSE (recording of orofacial manifestations in people with rare diseases) database. Br J Oral Maxillofac Surg 55:500–503. 2017;
5. Hanisch M, Hanisch L, Kleinheinz J, Danesh G, Benz K, Jackowski J. Orthodontically relevant manifestations in people with rare diseases. Med Princ Pract 28:216–221. 2019;
6. Molina-García A, Castellanos-Cosano L, Machuca-Portillo G, Posada-de la Paz M. Impact of rare diseases in oral health. Med Oral Patol Oral Cir Bucal 21:e587–594. 2016;
7. Rizkallah J, Schwartz S, Rauch F, Glorieux F, Vu DD, Muller K, Retrouvey JM. Evaluation of the severity of malocclusions in children affected by osteogenesis imperfecta with the peer assessment rating and discrepancy indexes. Am J Orthod Dentofacial Orthop 143:336–341. 2013;
8. Ribeiro EM, Fonteles CS, Freitas AB, da Silva Alves KS, Monteiro AJ, Bruno da Silva CA. A clinical multicenter study of orofacial features in 26 Brazilian patients with different types of mucopolysaccharidosis. Cleft Palate Craniofac J 52:352–358. 2015;
9. Mikkola ML. Molecular aspects of hypohidrotic ectodermal dysplasia. Am J Med Genet A 149A:2031–2036. 2009;
10. Toupenay S, Razanamihaja N, Berdal A, Boy-Lefevre ML. Rare diseases with oral components: care course and quality of life. Community Dent Health 30:10–14. 2013;
11. Luo E, Liu H, Zhao Q, Shi B, Chen Q. Dental-craniofacial manifestation and treatment of rare diseases. Int J Oral Sci 11:9. 2019;
12. Axelsson S, Bjørnland T, Kjær I, Heiberg A, Storhaug K. Dental characteristics in Williams syndrome: a clinical and radiographic evaluation. Acta Odontol Scand 61:129–136. 2003;
13. Ahmed B, Yazdanie N. Hypodontia and microdontia associated with hereditary ectodermal dysplasia. J Coll Physicians Surg Pak 19:192–194. 2009;
14. Nunes DO, Pinto A, Albuquerque T, Luís H, Graça SR, Bizarra F. Oral health status and oral habits: a study on 33 rare diseases. Rev Port Estomatol Med Dent Cir Maxilofac 65:66–75. 2023;
15. Vettore MV, Borges-Oliveira AC, Prado HV, de Almeida Lamarca G, Owens J. Rare genetic diseases affecting skeletal development and oral health disparities among children and adolescents: A pathway analysis. Int Dent J 70:469–476. 2020;
16. Shaw L, Shaw MJ, Foster TD. Correlation of manual dexterity and comprehension with oral hygiene and periodontal status in mentally handicapped adults. Community Dent Oral Epidemiol 17:187–189. 1989;
17. Thornton JB, Al‐Zahid S, Campbell VA, Marchetti A, Bradley Jr EL. Oral hygiene levels and periodontal disease prevalence among residents with mental retardation at various residential settings. Spec Care Dentist 9:186–190. 1989;
18. Prado HV, Carneiro NCR, Perazzo MF, de Abreu MHNG, Martins CdC, Borges-Oliveira AC. Assessing a possible vulnerability to dental caries in individuals with rare genetic diseases that affect the skeletal development. Orphanet J Rare Dis 14:145. 2019;
19. Wiemann S, Frenzel Baudisch N, Jordan RA, Kleinheinz J, Hanisch M. Oral symptoms and oral health-related quality of life in people with rare diseases in Germany: a cross-sectional study. Int J Environ Res Public Health 15:1493. 2018;
20. Sjögreen L, Andersson-Norinder J, Bratel J. Oral health and oromotor function in rare diseases - A database study. Swed Dent J 39:23–37. 2015;
21. Friedlander L, Vincent M, Berdal A, Cormier-Daire V, Lyonnet S, Garcelon N. Consideration of oral health in rare disease expertise centres: a retrospective study on 39 rare diseases using text mining extraction method. Orphanet J Rare Dis 17:317. 2022;
22. Sjögreen L, Mogren Å, Andersson‐Norinder J, Bratel J. Speech, eating and saliva control in rare diseases - a database study. J Oral Rehabil 42:819–827. 2015;
23. Friedlander L, Berdal A, Boizeau P, Licht BA, Manière MC, Picard A, Azzis O, Vazquez MP, Alberti C, Molla MDLD. Oral health related quality of life of children and adolescents affected by rare orofacial diseases: a questionnaire-based cohort study. Orphanet J Rare Dis 14:124. 2019;
24. Rana MA, Akram A, Husain D, Iqbal H, Said W, Khan SM. Dental Treatment and Quality of Life in Rare Syndromes. Pakistan J Med Health Sci 17:309–311. 2023;
25. Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, Murphy D, Le Cam Y, Rath A. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet 28:165–173. 2020;
26. Stojković B, Igić M, Janjić OT, Igić A, Čemerikić L, Veličković Z, Stojanović S, Petrović M. The Importance of Preventive Dental Health Care in Children with Rare Diseases. Prev Ped 9:32–36. 2023;
27. Ministry of Health and Welfare of the Republic of Korea. Current status of regional dental care centers for persons with disabilities in Korea. Available from URL: https://www.mohw.go.kr/menu.es-?mid=a10706030200 (Accessed on January 5, 2025).
28. Korean Disease Control and Prevention Agency. Current status of regional specialized institutions for patient with rare disease in Korea. Available from URL: https://helpline.kdca.go.kr/cdchelp/ph/supbiz/select-MedOrgList.do?menu=D0200 (Accessed on February 20, 2025).
29. Kühne A, Kleinheinz J, Jackowski J, Köppe J, Hanisch M. Study to investigate the knowledge of rare diseases among dentists, orthodontists, periodontists, oral surgeons and craniomaxillofacial surgeons. Int J Environ Res Public Health 18:139. 2020;
30. Benz K, Trapp R, Voss M, Hanisch M, Geisthoff U, Jackowski J. Awareness and knowledge of rare diseases in German dentists, dental specialists and oral and maxillofacial surgeons: a country-wide survey. Medicina 58:1114. 2022;
31. da Rosa SV, Moysés SJ, Theis LC, Soares RC, Moysés ST, Werneck RI, Rocha JS. Barriers in access to dental services hindering the treatment of people with disabilities: a systematic review. Int J Dent 2020:9074618. 2020;
32. Korea Disease Control and Prevention Agency. The rare disease special case program in Korea. Available from URL: https://helpline.kdca.go.kr/cdchelp/ph/ptlcontents/selectPtlConSent.do?menu=B0301&schSno=122 (Accessed on January 5, 2025).
33. Health Insurance Review & Assessment Service. Insurance coverage criteria for preventive treatment of dental caries using fluoride in Korea. Available from URL: https://www.hira.or.kr/rc/insu/insuadtcrtr/InsuAdtCrtrPopup.do?mtgHmeDd=20230329&sno=3&mtgMtrRegSno=30&brdScn-BltNo=4&brdBltNo=&isPopupYn=Y (Accessed on February 21, 2025).
34. Health Insurance Review & Assessment Service. Insurance coverage criteria for general anesthesia in dental care for patients with disabilities. Available from URL: https://www.hira.or.kr/rc/insu/insuadtcrtr/InsuAdtCrtrPopup.do?mtgHmeDd=20220201&sno=6&mtgMtrRegSno=1&brdScn-BltNo=4&brdBltNo=&isPopupYn=Y (Accessed on February 21, 2025).
35. Joo Y, Lee J, Choi HJ, Song JS, Lee KE, Kang CM. Dental Treatment Patterns in Pediatric Patients with Rare Diseases: A Retrospective Analysis at Yonsei University Dental Hospital. J Korean Acad Pediatr Dent 51:417–431. 2024;
36. Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, Sherman SL, Reeves RH. Down syndrome. Nat Rev Dis Primers 6:9. 2020;
37. Craig B. Atrioventricular septal defect: from fetus to adult. Heart 92:1879–1885. 2006;
38. Johnson D, Wilkie AO. Craniosynostosis. Eur J Hum Genet 19:369–376. 2011;
39. Cerruti Mainardi P. Cri du Chat syndrome. Orphanet J Rare Dis 1:33. 2006;
40. Moskovitz M, Brener D, Faibis S, Peretz B. Medical considerations in dental treatment of children with Williams syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99:573–580. 2005;
41. Arzimanoglou A, French J, Blume WT, Cross JH, Ernst JP, Feucht M, Genton P, Guerrini R, Kluger G, Pellock JM, Perucca E, Wheless JW. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 8:82–93. 2009;
42. D’Alonzo R, Rigante D, Mencaroni E, Esposito S. West syndrome: a review and guide for paediatricians. Clin Drug Investig 38:113–124. 2018;
43. Cherian A, Thomas SV. Status epilepticus. Ann Indian Acad Neurol 12:140–153. 2009;
44. Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Rev Dis Primers 7:13. 2021;
45. Ihara M, Yamamoto Y, Hattori Y, Liu W, Kobayashi H, Ishiyama H, Yoshimoto T, Miyawaki S, Clausen T, Bang OY, Steinberg GK, Tournier-Lasserve E, Koizumi A. Moyamoya disease: diagnosis and interventions. Lancet Neurol 21:747–758. 2022;
46. Mowat D, Wilson M. Mowat-Wilson syndrome. In: Carey JC, Battaglia A, Viskochil D, Cassidy SB, editors. Cassidy and Allanson’s Management of Genetic Syndromes, 4th ed. Wiley-Blackwell, Hoboken, 597-609, 2020.
47. Nagpal R, Goyal RB, Priyadarshini K, Kashyap S, Sharma M, Sinha R, Sharma N. Mucopolysaccharidosis: A broad review. Indian J Ophthalmol 70:2249–2261. 2022;
48. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet 381:242–255. 2013;
49. Gold WA, Percy AK, Neul JL, Cobb SR, Pozzo-Miller L, Issar JK, Ben-Zeev B, Vignoli A, Kaufmann WE. Rett syndrome. Nat Rev Dis Primers 10:84. 2024;
50. Ministry of Health and Welfare of the Republic of Korea. Expansion of insurance coverage for orthodontic treatment of congenital craniofacial anomalies. Available from URL: https://www.mohw.go.kr/board.es?mid=a10503010100&bid=0027&act=view&list_no=368040&tag=&nPage=195 (Accessed on February 21, 2025).

Article information Continued

Fig 1.

Survey questionnaire on dental utilization among pediatric patients with rare diseases.

Fig 2.

Survey questionnaire on satisfaction with dental treatment for pediatric patients with rare diseases.

Fig 3.

Representative diseases according to rare disease classification.

Fig 4.

Caregivers’ perceptions of and satisfaction with dental care for pediatric patients with rare diseases. (A) Caregivers’ perceptions of the dental care utilization status for patients with rare diseases, (B) Caregivers’ perceptions of the oral and general health status of patients with rare diseases, (C) Caregivers’ perceptions of functional and psychological changes after dental treatment, (D) The average score for each response is displayed on the right side of the horizontal bar. Higher scores indicate more positive responses.

Fig 5.

Graphical summary of the main findings of this study.

This figure illustrates the factors contributing to the challenges in providing dental care for children with rare diseases (red arrows on the left) and the requirements for improving dental care for these patients (green arrows on the right).

Table 1.

Demographic characteristics of the study

Characteristics n (126) %
Sex Male 63 50
Female 63 50
Age at first dental visit 0 – 5 years 74 58.7
6 – 10 years 39 31.0
11 – 15 years 13 10.3
Residence Seoul 24 19.1
Gyeonggi 33 26.2
Jeolla 30 23.8
Gyeongsang 33 26.2
Others 6 4.8
Time of diagnosis of rare disease At birth 9 7.5
Within 1 year after birth 50 41.7
More than 1 year after birth 45 37.5
Unknown 16 13.3
Familial history of rare disease* Yes 1 0.9
No 66 55.9
Unknown 51 43.2
Medication for rare disease* Yes 75 61.5
No 20 16.4
Unknown 27 22.1
ASA class* 1 1 0.8
2 111 91.0
3 4 3.3
6 1 0.8
Unknown 5 4.1

ASA: American Society of Anesthesiologists.

*

Data were not available for some patients.

Table 2.

Dental care utilization status in pediatric patients with rare diseases based on the primary physician’s recommendation for oral care

Total (n = 126) Primary physician’s recommendation for dental check-ups/treatment Primary physician’s explanation of the importance of oral care
No (n = 68) Yes (n = 58) p-value No (n = 70) Yes (n = 56) p-value
Reason for dental visit* Regular check-ups 77 (61.1) 39 (57.4) 38 (65.5) 0.3488 36 (51.4) 41 (73.2) 0.0127ǁ
Primary physician’s recommendation 41 (32.5) 12 (17.7) 29 (50.0) 0.0001ǁ 19 (27.1) 22 (39.3) 0.1483
Difficulty eating 16 (12.7) 9 (13.2) 7 (12.1) 0.8446 10 (14.3) 6 (10.7) 0.5496
Pain 15 (11.9) 8 (11.8) 7 (12.1) 0.9581 8 (11.4) 7 (12.5) 0.8536
Other 11 (8.7) 8 (11.8) 3 (5.2) 0.1913 8 (11.4) 3 (5.4) 0.3433§
Aesthetic reasons 9 (7.1) 6 (8.8) 3 (5.2) 0.5048§ 5 (7.1) 4 (7.1) 1.0000§
Reasons for choosing dental hospital* Expertise of dental staff 69 (54.8) 34 (50.0) 35 (60.3) 0.2449 37 (52.9) 32 (57.1) 0.6310
Collaborative care with pediatrics 66 (52.4) 31 (45.6) 35 (60.3) 0.0983 35 (50.0) 31 (55.4) 0.5496
Dental equipment and facilities 50 (39.7) 28 (41.2) 22 (37.9) 0.7105 30 (42.9) 20 (35.7) 0.4154
Friendly dental staff 35 (27.8) 15 (22.1) 20 (34.5) 0.1207 16 (22.9) 19 (33.9) 0.1680
Recommendations and reputation 18 (14.3) 10 (14.7) 8 (13.8) 0.8840 11 (15.7) 7 (12.5) 0.6084
Proximity 15 (11.9) 6 (8.8) 9 (15.5) 0.2475 8 (11.4) 7 (12.5) 0.8536
Quick appointment and treatment 15 (11.9) 4 (5.9) 11 (19.0) 0.0238ǁ 7 (10.0) 8 (14.3) 0.4604
Other 8 (6.4) 5 (7.4) 3 (5.2) 0.7249§ 3 (4.3) 5 (8.9) 0.4647§
Transportation to dental visit* Personal vehicle 106 (84.1) 56 (82.4) 50 (86.2) 0.5552 59 (84.3) 47 (83.9) 0.9565
Bus, subway 12 (9.5) 6 (8.8) 6 (10.3) 0.7719 5 (7.1) 7 (12.5) 0.3087
Transportation for people with disabilities 8 (6.4) 3 (4.4) 5 (8.6) 0.4688§ 3 (4.3) 5 (8.9) 0.4647§
Taxi 6 (4.8) 4 (5.9) 2 (3.5) 0.6860§ 3 (4.3) 3 (5.4) 1.0000§
Train, airplane 3 (2.4) 1 (1.5) 2 (3.5) 0.5941§ 2 (2.9) 1 (1.8) 1.0000§
Other 1 (0.8) 1 (1.5) 0 (0.0) 0.3538 0 (0.0) 1 (1.8) 0.4444§
Reasons for difficulty in dental visits* Child’s cooperation 55 (43.7) 30 (44.1) 25 (43.1) 0.9089 31 (44.3) 24 (42.9) 0.8724
Accessibility of specialized dental hospitals 38 (30.2) 20 (29.4) 18 (31.0) 0.8432 25 (35.7) 13 (23.2) 0.1287
Refusal of treatment at private dental clinics 38 (30.2) 24 (35.3) 14 (24.1) 0.1738 24 (34.3) 14 (25.0) 0.2591
Dental expenses 24 (19.1) 12 (17.7) 12 (20.7) 0.6646 8 (11.4) 16 (28.6) 0.0149ǁ
Other 9 (7.1) 5 (7.4) 4 (6.9) 1.0000§ 5 (7.1) 4 (7.1) 1.0000§
Transportation 7 (5.6) 4 (5.9) 3 (5.2) 1.0000§ 4 (5.7) 3 (5.4) 1.0000§
Dental check-ups frequency 3 months 52 (45.2) 29 (46.0) 23 (44.2) 0.6810§ 29 (44.6) 23 (46.0) 0.2917§
6 months 43 (37.4) 21 (33.3) 22 (42.3) 23 (35.4) 20 (40.0)
1 – 2 months 8 (7.0) 4 (6.4) 4 (7.7) 3 (4.6) 5 (10.0)
Only when uncomfortable 8 (7.0) 6 (9.5) 2 (3.9) 7 (10.8) 1 (2.0)
12 months 2 (1.7) 2 (3.2) 0 (0.0) 2 (3.1) 0 (0.0)
Other 2 (1.7) 1 (1.6) 1 (1.9) 1 (1.5) 1 (2.0)
Recently caries treatment in 6 months No 61 (52.1) 36 (56.3) 25 (47.2) 0.3277 37 (56.1) 24 (47.1) 0.3338
Yes 56 (47.9) 28 (43.8) 28 (52.8) 29 (43.9) 27 (52.9)

Values are presented as number (%).

*

: Multiple answers allowed;

: Data were not available for some patients;

: chi-square test;

§

: Fisher’s exact test;

ǁ

: p < 0.05.

Table 3.

Caregivers’ requests for improved dental care for children with rare diseases based on dental caries treatment experiences and rare disease classification

Total (n = 91) Recently dental caries treatment in 6 months Classification of rare disease
No (n = 37) Yes (n = 54) p-value Neurological disease (n = 21) Congenital disorder (n = 55) Other disease (n = 15) p-value
Financially burdensome dental treatment* General anesthesia and hospitalization 40 (31.8) 22 (36.1) 18 (32.1) 0.6550 10 (30.3) 22 (32.4) 8 (32.0) 0.9782
Orthodontic treatment 38 (30.2) 20 (32.8) 18 (32.1) 0.9408 6 (18.2) 27 (39.7) 5 (20.0) 0.0405§
Prosthetic treatment 38 (30.2) 16 (26.2) 22 (39.3) 0.1319 6 (18.2) 23 (33.8) 9 (36.0) 0.2137
Restorative treatment 19 (15.1) 6 (9.8) 13 (23.2) 0.0500 3 (9.1) 14 (20.6) 2 (8.0) 0.1726
Endodontic treatment 13 (10.3) 6 (9.8) 7 (12.5) 0.6469 3 (9.1) 8 (11.8) 2 (8.0) 0.8383
Fluoride application 6 (4.8) 2 (3.3) 4 (7.1) 0.4241 2 (6.1) 3 (4.4) 1 (4.0) 0.9171
Dental treatment that requires insurance coverage* Prosthetic treatment 59 (46.8) 25 (41.0) 34 (60.7) 0.0330§ 13 (39.4) 36 (52.9) 10 (40.0) 0.3294
Orthodontic treatment 58 (46.0) 27 (44.3) 31 (55.4) 0.2305 12 (36.4) 36 (52.9) 10 (40.0) 0.2329
General anesthesia and hospitalization 46 (36.5) 21 (34.4) 25 (44.6) 0.2584 10 (30.3) 29 (42.7) 7 (28.0) 0.2960
Restorative treatment 39 (31.0) 14 (23.0) 25 (44.6) 0.0129§ 8 (24.2) 25 (36.8) 6 (24.0) 0.3111
Endodontic treatment 27 (21.4) 11 (18.0) 16 (28.6) 0.1765 7 (21.2) 16 (23.5) 4 (16.0) 0.7346
Fluoride application 23 (18.3) 10 (16.4) 13 (23.2) 0.3537 7 (21.2) 11 (16.2) 5 (20.0) 0.8020
Dental care system that requires improvement* Increase in specialized dental care facilities 54 (42.9) 23 (37.7) 31 (55.4) 0.0557 14 (42.4) 31 (45.6) 9 (36.0) 0.7084
Expansion of insurance coverage 49 (38.9) 19 (31.2) 30 (53.6) 0.0141§ 10 (30.3) 29 (42.7) 10 (40.0) 0.4866
Increase in specialized dentists 42 (33.3) 22 (36.1) 20 (35.7) 0.9684 7 (21.2) 32 (47.1) 3 (12.0) 0.0015§
Collaborative care with pediatrics 32 (25.4) 17 (27.9) 15 (26.8) 0.8955 5 (15.2) 22 (32.4) 5 (20.0) 0.1388
Oral care information 14 (11.1) 6 (9.8) 8 (14.3) 0.4588 1 (3.0) 11 (16.2) 2 (8.0) 0.1229

Values are presented as number (%).

*

: Multiple answers allowed;

: chi-square test;

: Fisher’s exact test;

§

: p < 0.05.